Eligo Bioscience

About:

Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.

Website: https://eligo.bio/

Twitter/X: eligobio

Top Investors: Khosla Ventures, Bpifrance, European Commission, Seventure Partners, AGORANOV

Description:

Eligobiotics is a developer of antibiotics intended to treat microbiome precision and bacteria-associated diseases. The company's antibiotics combine CRISPR/Cas system with engineered phage capsids, to develop antimicrobials that are used to eradicate resistant pathogens or virulent bacteria within the human microbiome, enabling clients to get next-generation antimicrobials to treat diseases caused by superbugs.